Skip to main content
SpringerLink
Log in
Book cover

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

  • Conference proceedings
  • © 2004

Overview

Editors:
  1. Masao Omata

    1. Department of Gastroenterology Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Kiwamu Okita

    1. Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine, Yamaguchi, Japan

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Providing most up-dated information on anti-viral treatment for HCV

  • Including concrete evidence that the anti-viral prevented the incidence of HCC

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (29 papers)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Opening Lecture: What is Accomplished and What is Needed

      • Masao Omata
      Pages 3-21

  3. Lamivudine Therapy for Hepatitis B

    1. Front Matter

      Pages 23-23
      Download chapter PDF

    2. New Anti-Virals Against Wild-Type and Lamivudine-Resistant Hepatitis B Virus

      • Naoya Kato, Suzane Kioko Ono-Nita, Masao Omata
      Pages 25-31

    3. Lamivudine Therapy of Hepatitis B in Japan

      • Michio Sata
      Pages 32-37

    4. Early Detection of Lamivudine Resistant Mutant in Chronic Hepatitis B Patients Using a Novel Sensitive Method

      • Takeshi Okanoue, Kohjiro Mori, Toshihiko Kirishima, Masahito Minami
      Pages 38-44

  4. New Anti-Virals: HBV

    1. Front Matter

      Pages 45-45
      Download chapter PDF

    2. New Antiviral Treatment for Chronic Hepatitis B

      • Man-Fung Yuen, Ching-Lung Lai
      Pages 47-56

    3. New Antiviral Therapy: Adefovir Dipivoxil for HBV

      • Marion Peters
      Pages 57-62

    4. Development of Entecavir: Superior Therapy for the Management of Chronic Hepatitis B Viral Infection

      • Deborah DeHertogh, Richard Colonno, William Fiske, Anne Cross
      Pages 63-73

  5. Therapy for Hepatitis B and Prevention of HCC

    1. Front Matter

      Pages 75-75
      Download chapter PDF

    2. Therapy of Hepatitis B and Prevention of Hepatocellular Carcinoma

      • Nancy Leung
      Pages 77-83

    3. Differences of Clinical Characteristics Among Japanese Patients with Hepatitis B Virus Genotypes B and C

      • Masashi Mizokami, Etsuro Orito
      Pages 84-93

  6. HCV Replicon System

    1. Front Matter

      Pages 95-95
      Download chapter PDF

    2. Establishment of a New Hepatitis C Virus-1 b Replicon

      • Nobuyuki Enomoto, Naoya Sakamoto, Masayuki Kurosaki, Shinya Maekawa, Yoko Tanabe, Tsuyoshi Yamashiro et al.
      Pages 97-107

    3. Hepatitis C Virus Replication in Cell Culture

      • Michael Frese, Volker Lohmann, Thomas Pietschmann, Artur Kaul, Nicole Krieger, Jens Bukh et al.
      Pages 108-122

    4. Characterization of the Interferon Alpha Response Against HCV in Hepatoma Cells

      • Christoph Seeger, Qing Zhu, Ju-Tao Guo
      Pages 123-130

  7. New Anti-Virals: HCV

    1. Front Matter

      Pages 131-131
      Download chapter PDF

    2. Hepatitis C: Development of a Ribavirin Liver-Targeting Prodrug

      • Johnson Y. N. Lau
      Pages 133-139
Back to top

Keywords

About this book

The liver has an important role in nutritional homeostasis, and it is well known that liver diseases can lead to abnormalities in the nutrient metabolism and to subsequent malnutrition. Because malnutrition is particularly prevalent in patients with liver cirrhosis, proper nutritional assessment and support for cirrhotic patients is essential. This collection of research and clinical findings on nonalcoholic steatohepatitis (NASH) and nutritional therapy contains significant new findings in several fields. As NASH frequently causes liver cirrhosis, the nutritional aspects of its treatment are discussed. Other areas covered include nonalcoholic fatty liver, the role of leptin in the pathogenesis of NASH, restricted diets and exercise therapy, mammalian targets of the peptide rapamycin, and genetic factors influencing the development of NASH. This book is intended to be of particular relevance to researchers and those practicing in the field.


Editors and Affiliations

  • Department of Gastroenterology Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Masao Omata

  • Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine, Yamaguchi, Japan

    Kiwamu Okita

About the editors

Kiwamu OkitaProfessor, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine

Bibliographic Information

  • Book Title: Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

  • Editors: Masao Omata, Kiwamu Okita

  • DOI: https://doi.org/10.1007/978-4-431-53977-3

  • Publisher: Springer Tokyo

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Japan 2004

  • Hardcover ISBN: 978-4-431-40280-0Published: 19 January 2004

  • Softcover ISBN: 978-4-431-67975-2Published: 05 November 2012

  • eBook ISBN: 978-4-431-53977-3Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XI, 295

  • Topics: Hepatology, Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation